Filing metadata

Accession number
0001562180-19-003669
Form type
Form 4
Filer
EyePoint Pharmaceuticals, Inc.
CIK
CIK 1314102
Filed
Jun 27, 2019
Reporting period
Jun 25, 2019
Description
Insider transaction

Explore SEC Filings Hub